PARIS — The Việt Nam Vaccine Joint Stock Company (VNVC) and Sanofi on Tuesday signed a document guiding the cooperation in manufacturing some vaccines of the French pharmaceutical group in the Southeast Asian country. Accordingly, Sanofi will broadly share its knowledge and expertise on biotechnology with the Vietnamese partner to create conditions for gradually manufacturing essential vaccines at the VNVC factory in Việt Nam. This important partnership will not only facilitate Vietnamese people’s access to vaccines but also help ensure stable vaccine supply and reduce many expenses. In Việt Nam, it supplied more than 7 million high-quality vaccine doses in 2023. It prioritises cooperation with Sanofi and other pharmaceutical firms so as to manufacture important vaccines and drugs, helping ensure sufficient supply for Việt Nam.
